Effect of Adapted Physical Activity on Emotion Regulation in People With Depressive Disorders (REAPAD)
21 août 2026 mis à jour par: Centre Hospitalier Georges Mazurelle
Impact d'un Programme d'activité Physique adaptée Sur la régulation Des émotions de Personnes Souffrant de Troubles dépressifs, en Sortie d'Hospitalisation : étude REAPAD
Depression is associated with difficulties in emotion regulation. Adapted physical activity (APA) may help improve emotional regulation in people with depressive disorders.
The REAPAD study evaluates the effects of an adapted physical activity program on emotion regulation in adults with depressive disorders following psychiatric hospitalization. Participants were randomly assigned to one of two APA programs: a standard adapted physical activity program or a combined adapted physical activity program including activities specifically targeting emotional regulation.
Emotion regulation is assessed using the Cognitive Emotion Regulation Questionnaire (CERQ). The study also evaluates depressive symptoms, anxiety, self-esteem, physical activity, physical condition, and other psychological and physical outcomes.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Réel)
45
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Vendée
-
La Roche-sur-Yon, Vendée, France, 85 000
- EPSM de Vendée - Centre Hospitalier Georges Mazurelle
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- Age over 18 years
- Unipolar or bipolar depressive disorder
- Discharged from full hospitalization, up to three weeks after discharge
- Able to provide free and informed consent
- Not participating in any other research
Exclusion Criteria:
- High suicidal risk, at the investigator's discretion
- Medical contraindication to any physical activity
- Motor, psychological, or intellectual disability, or other medical condition, at the investigator's discretion, preventing full participation in the study
- Severe addictive disorder impeding participation in the study
- Psychotic disorder
- Pregnancy or breastfeeding
- Any circumstances rendering the participant unable to understand the nature, purpose, or consequences of the trial
- Under legal protection (guardianship or trusteeship)
- No social security coverage
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Classical Adapted Physical Activity
|
Participants received an individualized, moderate-intensity adapted physical activity program consisting of 8 sessions over 6 weeks, with at least one session per week.
The program included aerobic training (step-based exercises, lateral stepping and locomotor circuit tasks), lower-limb resistance training (chair stands, step-ups, lateral stepping and lunges), and agility and coordination exercises (agility ladder drills and motor circuit tasks).
Session duration progressively increased from 25 minutes for sessions 1 and 8 to 30, 35 and 40 minutes for the intermediate sessions.
Each session included a 5-minute warm-up and muscular flexibility period and a 10-minute cool-down period.
|
|
Expérimental: Combined Adapted Physical Activity Program
|
Participants received an individualized, moderate-intensity adapted physical activity program consisting of 8 sessions over 6 weeks, with at least one session per week.
The program included aerobic training, lower-limb resistance training, and agility and coordination exercises.
In addition, cognitive and emotional training tasks were integrated into the physical activity sessions.
Cognitive tasks included short-term memory activities, verbal fluency dual tasks and cognitive flexibility exercises.
Emotional tasks included identifying, recognizing and expressing emotions using images and photographs of facial expressions.
These cognitive and emotional tasks were incorporated during exercises and rest periods throughout the program.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in emotion regulation strategies assessed by the Cognitive Emotion Regulation Questionnaire (CERQ
Délai: Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
Emotion regulation strategies are assessed using the Cognitive Emotion Regulation Questionnaire (CERQ), a 36-item self-administered questionnaire comprising nine subscales.
Items are rated from 1 (almost never) to 5 (almost always), providing scores for adaptive and maladaptive cognitive emotion regulation strategies
|
Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Depressive Symptom Severity Assessed by the Montgomery-Åsberg Depression Rating Scale (MADRS
Délai: Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
Depressive symptom severity is assessed using the Montgomery-Åsberg Depression Rating Scale (MADRS).
The scale consists of 10 items assessing depressive symptoms, each rated from 0 to 6.
The total score ranges from 0 to 60, with higher scores indicating greater severity of depressive symptoms.
|
Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
|
Change in Cognitive Flexibility Assessed by the Trail Making Test (TMT)
Délai: Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
Cognitive functioning is assessed using the Trail Making Test (TMT).
The test includes Part A and Part B. Performance is assessed using the time required to complete each part, with longer completion times indicating poorer performance.
|
Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
|
Change in Subjective Vitality Assessed by the Subjective Vitality Scale
Délai: Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
Subjective vitality is assessed using the Subjective Vitality Scale.
The scale consists of 5 items rated from 1 to 7 and assesses the participant's subjective experience of physical and psychological energy and vitality.
Higher scores indicate greater subjective vitality
|
Baseline (T0), immediately after completion of the 6-week intervention (T1), and 6 weeks after the end of the intervention (T2)
|
|
Change in Mood States Assessed by the Profile of Mood States (POMS-F)
Délai: Immediately before and immediately after each adapted physical activity session
|
Mood states are assessed using the French version of the Profile of Mood States (POMS-F), a 65-item self-administered questionnaire.
The questionnaire assesses seven transient and fluctuating mood dimensions: tension-anxiety, anger-hostility, confusion-bewilderment, depression-dejection, fatigue-inertia, vigor-activity, and interpersonal relations.
Items are rated on a 5-point Likert scale.
An overall psychological distress score is calculated by summing the tension-anxiety, anger-hostility, confusion-bewilderment, depression-dejection, and fatigue-inertia scores and subtracting the vigor-activity score.
Higher psychological distress scores indicate greater mood disturbance.
Mood state is assessed using the French version of the Profile of Mood States (POMS-F).
The POMS-F consists of 65 items rated from 0 (not at all) to 4 (extremely).
The Global Score is calculated as the sum of Anxiety-Tension, Anger-Hostility, Confusion-Bewilderment, Depression-Dejection, and Fatigue-Inertia scores
|
Immediately before and immediately after each adapted physical activity session
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Publications générales
- Longuechaud C, Videau Villeneuve F, Bulteau F, Valot I, Douet M, Bulteau S, Deschamps T, Sauvaget A. The effect of adapted physical activity programs on the regulation of emotions in people suffering from major depressive disorders after hospital discharge: REAPAD study protocol. Minerva Psychiatry. 2026;67(2):82. doi:10.23736/S2724-6612.26.02669-2.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
10 février 2023
Achèvement primaire (Réel)
30 avril 2026
Achèvement de l'étude (Réel)
30 avril 2026
Dates d'inscription aux études
Première soumission
19 août 2026
Première soumission répondant aux critères de contrôle qualité
19 août 2026
Première publication (Réel)
21 août 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
24 août 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
21 août 2026
Dernière vérification
1 août 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2022-A02099-34
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .